For more information and access to our Research reports please contact Luke Kottke or Matthew Moschovas on the Capital Markets desk – 212.953.4917/4949 or lkottke@laidlawltd.com
Coverage List
ADMA Biologics (ADMA) | Delcath Systems (DCTH) | OPKO Health, Inc. (OPK) |
Affimed (AFMD) | Evoke Pharma (EVOK) | Plus Therapeutics (PSTV) |
Aldeyra Therapeutics (ALDX) | Eyepoint Pharmaceuticals (EYPT) | Sesen Bio (SESN) |
Arcturus Therapeutics (ARCT) | F-Star Therapeutics (FSTX) | Soleno Therapeutics (SLNO) |
Athenex (ATNX) | Hoth Therapeutics (HOTH) | Taiwan Liposome Company (TLC) |
aTyr Pharma (LIFE) | iCAD Inc. (ICAD) | Viking Therapeutics (VKTX) |
Beyond Air (XAIR) | Ionis Pharmaceuticals (IONS) | Ziopharm Oncology (ZIOP) |
BioSig Technologies (BSGM) | MEI Pharma (MEIP) | |
Curis Inc (CRIS) | Molecular Templates (MTEM) |